2026 RNDS | Welcome Remarks and Conference Orientation @wearesrna
2026 RNDS | Welcome Remarks and Conference Orientation  @wearesrna
Uploaded October 2026 | Updated November 2026, 3 hours ago
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Benjamin Greenberg, MD, MHS, of the University of Texas Southwestern and Carlos A. Pardo, MD, of Johns Hopkins University welcomed attendees to Texas and thanked SRNA staff and the symposium sponsors [00:00:05]. Dr. Greenberg ran a live Slido poll asking for one word that describes what people hope to gain from RNDS, and knowledge, hope, education, connection and community rose to the top [00:01:31]. The two reflected on why the symposium has stayed in person for 27 years, and Dr. Greenberg previewed the afternoon: a community panel on diagnosis, a diagnostic workup discussion, and two talks on new diagnostic criteria [00:04:25]. Dr. Pardo recalled how the Transverse Myelitis Association began in the 1990s, how the Johns Hopkins transverse myelitis center and patient registry started in 1999, and how antibody discoveries changed care for neuromyelitis optica and MOG antibody disease (MOGAD) [00:09:10]. He closed by describing what the weekend would cover, from diagnosis updates to long-term management [00:13:18].

Benjamin Greenberg, MD, MHS, received his bachelor's degree from Johns Hopkins University and his master's degree in molecular microbiology and immunology from the Johns Hopkins School of Public Health. He attended medical school at Baylor College of Medicine and completed his neurology residency at The Johns Hopkins Hospital, where he later became Co-Director of the Transverse Myelitis Center. In 2009 he was recruited to the University of Texas Southwestern Medical Center, where he directs the Transverse Myelitis and Neuromyelitis Optica Program and established the Pediatric Demyelinating Disease Program at Children's Medical Center Dallas. He is recognized internationally as an expert in rare autoimmune disorders of the central nervous system, including transverse myelitis, neuromyelitis optica spectrum disorder, ADEM and autoimmune encephalitis.

Carlos A. Pardo, MD, is a Professor of Neurology and Pathology in the Division of Neuroimmunology and Neuroinfectious Disorders at Johns Hopkins University School of Medicine and Director of the Johns Hopkins Myelitis and Myelopathy Center in Baltimore, Maryland. He is the principal investigator of the Neuroimmunopathology Laboratory and a clinical neurologist at the Multiple Sclerosis and Transverse Myelitis Centers at Johns Hopkins Hospital. His clinical specialization is neuroimmunological and infectious disorders of the nervous system, with particular focus on multiple sclerosis, transverse myelitis, neurosarcoidosis, and neurological complications of autoimmune disorders.

00:00 Welcome to Texas and Thank You
01:31 Slido Poll: Hopes for RNDS
03:38 Words for the SRNA Community
04:25 Why We Meet in Person
06:25 What to Expect Today
09:10 Dr. Pardo's Welcome
10:22 Starting the Myelitis Center at Johns Hopkins
12:13 Twenty-Five Years of Progress
13:18 Looking Ahead to the Weekend
2026 RNDS | Welcome Remarks and Conference Orientation2024 RNDS | Plasma Exchange for Acute Inflammatory Demyelination: How We Got Here and Where to Next?2026 RNDS | CAR-T Trials for NMOSD2024 RNDS | Rare Neuroimmune Disorders: Diagnostic Criteria2024 RNDS | Management of Visual Symptoms2024 RNDS | Management of Neuropathic Pain: Medical and Surgical Options2023 RNDS | A conversation on disability and rare neuroimmune disorders2026 RNDS | New Diagnostic Criteria Update: NMOSD and Criteria Q&A202. Dr. Michael Levy203. Dr. Monica Diaz301. Significance of Brain Lesions in Pediatric MOGAD2024 RNDS | Understanding Genetics of Rare Neuroimmune Disorders
SRNA |

2026 RNDS | Welcome Remarks and Conference Orientation

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER